TLR-4 activation also increases iNOS expression, leading to an increase in serum NO levels, which contribute to an oxidative stress response that potentiates hyperglycemia and insulin resistance (Sugita et al., 2002). The gene discussed is TLR4; the disease is Hyperglycemia.